Stocks · Health care · Pharmaceutical Preparations

Kura Oncology, Inc.

KURA Clue Score49
United States Fiscal year ends December CIK 0001422143 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Troy Edward Wilson
24 Aug 2026
President and CEO
Buy indirect
100,000
$12.39
$1.24M
Troy Edward Wilson
17 Aug 2026
President and CEO
Buy indirect
100,000
$11.12
$1.11M

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 3
Sales at will 25
Transactions with no price 0
Shares from compensation/vesting 749,020
History held since 10 Mar 2015